IndiaTickerSMS Pharmaceuticals Ltd - 532815 - Update on board meetingBSE · exchange filing · pdf
Source filing Company dossier
SMS Pharmaceuticals
NSE:SMSPHARMA · ISIN INE812G01025
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
SMS Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026BSE · financial results · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)BSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing General Updates - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.BSE · exchange filing · pdf
Source filing General Updates - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Spurt in Volume - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Clarification On Volume/Price MovementBSE · exchange filing · pdf
Source filing Trading Window - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing General Updates - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.BSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - SMS Pharmaceuticals LimitedNSE · conference call · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · zip
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - SMS Pharmaceuticals LimitedNSE · conference call · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing Press Release - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing General Updates - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Registered Office AddressBSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Statement Of Deviation & Variation For The Quarter Ended 31St March, 2026BSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Dividend UpdatesBSE · corporate action · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Board Meeting Outcome for Approval Of Financial Results For The Fourth Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Financial Results For The 4Th Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Address Change - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - SMS Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - SMS Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Outcome of Board Meeting - SMS Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Integrated Filing- Financial - SMS Pharmaceuticals LimitedNSE · financial results · pdf
Source filing